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Host Defense Peptides (HDPs) are small cationic peptides found in several organisms.
They play a vital role in innate immunity response and immunomodulatory stimulation.
This investigation was designed to study the antimicrobial activities of β-defensin
peptide-4 (sAvBD-4) and 10 (sAvBD-4) derived from chickens against pathogenic
organisms including bacteria and fungi. Ten bacterial strains and three fungal species
were used in investigation. The results showed that the sAvBD-10 displayed a higher
bactericidal potency against all the tested bacterial strains than that of sAvBD-4. The
exhibited bactericidal activity was significant against almost the different bacterial strains
at different peptide concentrations except for that of Pseudomonas aeruginosa (P.
aeruginosa) and Streptococcus bovis (Str. bovis) strains where a moderate effect was
noted. Both peptides were effective in the inactivation of fungal species tested yielding a
killing rate of up to 95%. The results revealed that the synthetic peptides were resistant
to salt at a concentration of 50mM NaCl. However, they lost antimicrobial potency when
applied in the presence of high salt concentrations. Based on blood hemolysis studies,
a little hemolytic effect was showed in the case of both peptides even when applied at
high concentrations. The data obtained from this study indicated that synthetic avian
peptides exhibit strong antibacterial and antifungal activity. In conclusion, future work
and research should be tailored to a better understanding of the mechanisms of action
of those peptides and their potential use in the pharmaceutical industry to help reduce
the incidence and impact of infectious agent and be marketed as a naturally occurring
antibiotic.
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Introduction
Host Defense Peptides (HDPs) are a diverse group of small
and cationic peptides that are present in several organisms
(Cuperus et al., 2013). Originally, they were called Antimicrobial
Peptides (AMPs) due to their ability to inactivate and con-
trol bacteria in vitro. Several studies showed that these pep-
tides have additional functions, mainly immunomodulatory ones
(Cuperus et al., 2013). Therefore, they were named as “Host
Defense Peptides (HDPs).” Recently, some reports indicated that
HDPs are responsible for differentiation, activation and chemo-
taxis of leukocytes. They inhibited Lipopolysaccharide (LPS),
enhance phagocytosis, DNA uptake and wound healing (Zanetti,
2005; Semple and Dorin, 2012).
HDPs were first discovered in the 1970’s by extraction from
tissues of avian species (Evans et al., 1994). Based on new
advances in the field of bioinformatics and available sequence
data, a number of new HDPs have been identified. The first
avian HDPs were confirmed in the mid 1990’s, and included
five defensins isolated from the leukocytes of some avian species
like chickens and turkeys (Evans et al., 1994). Recently, the
complete defensin and cathelicidin genes clusters have been
sequenced for chickens. Due to the interest in their role as
potential therapeutically agents, there is a remarkable amount of
information based on various studies using other avian species
(Cuperus et al., 2013). Currently, there is a lot of research
on the role of these peptides as templates for possible novel
anti-microbial agents (Cuperus et al., 2013). Accordingly, they
have been sought as possible alternatives to antibiotics which
lost their shine due to the increasing resistance that is exhib-
ited against a wide range of bacteria which is a major public
health issue especially during the last decade (Cuperus et al.,
2013). Defensins peptides are cysteine-rich, cationic in nature
and composed of three conserved disulfide bridges, a β-sheet
and both hydrophobic and cationic amino acids (Ganz, 2003;
Selsted and Ouellette, 2005). The defensin peptides are classi-
fied into three main groups: α−, β−, and θ−defensins (Yang
et al., 2004; Selsted and Ouellette, 2005). Alpha-defensins are
found in mammals and form disulfide bridges between Cys1–
Cys6, Cys2–Cys4, and Cys3–Cys5 (Lehrer and Ganz, 2002; Yang
et al., 2004). Theta-defensins are present in all vertebrates and
form disulfide bonds between Cys1–Cys5, Cys2–Cys4, and Cys3–
Cys6 (Lehrer and Ganz, 2002; Klotman and Chang, 2006). Based
on extensive search and based on chicken genome analysis, β-
defensins were the first to be confirmed which derived from
avians species. Using the chicken genome, they were first to
be confirmed in avian species (Lehrer and Ganz, 2002; Klot-
man and Chang, 2006). The underlying mechanism by which
AMPs exert their effect is through their interaction with the neg-
atively charged phosolipid bilayer found in the cell membrane
under hydrophobic conditions, thus resulting in disruption and
killing of the pathogen (Higgs et al., 2005; Lynn et al., 2007).
It has been reported that avian β-defensin are more efficient
against Gram-positive bacteria than Gram-negative bacteria due
to their structural conformation (Cuperus et al., 2013). The mode
of action of theses peptides in bacterial killing was reported in
some studies due to its net charge. Some studies revealed that
the duck β−defensin-12 has the lowest net charge and lower
antibacterial activity as compared to duck β−defensin 4 and
7 peptides (Powers and Hancock, 2003; Ganz, 2004; Brogden,
2005).
This study was designed to evaluate the antimicrobial
activities of synthetic chicken β-defensin peptides (sAvBD-4
and 10) against both pathogenic Gram-negative and Gram-
positive bacteria and fungi. The kinetics were also inves-
tigated and the effect of salinity on their activity was
delineated.
Material and Methods
Bacterial Species
Bacterial species used included both Gram-negative and
Gram-positive strains. The five Gram-positive bacterial strains
used were: Micrococcus luteus ATCC 49732 (M. Luteus), Ente-
rococcus faecalis ATCC 29212 (Ent. faecalis), Streptococcus bovis
ATCC 49147 (Str. bovis), Staphylococcus epidermidis ATCC
12228 (Staph. epidermidis) and Methicillin-Resistance Staphy-
lococcus aureus ATCC 43330 (MRSA). Five strains of Gram-
negative bacteria included: Pseudomonas aeruginosa ATCC
27853 (P. aeruginosa), Escherichia coli ATCC 25922 (E. coli),
Salmonella typhimurium ATCC 14028 (Salm. typhimurium),
Klebsiella pneumonia ATCC 700603(Kleb. pneumonia), Shigella
sonnei ATCC 25931(Sh. sonnei). The bacterial strains were cul-
tured on tryptone soy agar and incubated for 24 h at 37◦C and
stored in slants at 4◦C.
Fungal Species
Three types of fungal species were used; Candida albicans
ATCC 10231 (C. albicans), Aspergillus flavus (Asp. flavus), and
Aspergillus niger (Asp. niger) isolates (obtained from the Depart-
ment of Biological Sciences, King Abdulaziz University, Jeddah,
Saudi Arabia. Filamentous fungi and Candida were cultured in
Sabouraud dextrose agar and incubated at 25–28◦C for 72 h for
multicellular fungi and h at 30◦C for 24 in the case of Candida
and stored in slants at 4◦C.
Chicken β-Defensins Peptides Synthesis
The mature peptide of chicken β-defensin (AvBD-4 and 10)
were custom synthesized and purified to 80% level using high-
performance liquid chromatography (HPLC) by GL Biochem
Ltd. (Shanghai, China) (http://www.glschina.com/en/profile.
htm). The full sequence of amino acids of chicken β-defensin
(AvBD-4 and 10) are listed in Table 1.
TABLE 1 | Amino acid sequence of synthetic AvBDs.
Amino acid sequence AA
AvBD-4 AC-MKILCFFIVLLFVAVHGAVGFSRSPRYHM
QCGYRGTFCTPGKCPHGNAYLGLCRPKYSCCRWL
64
AvBD-10 AC-MKILCLLFAVLLFLFQAAPGSADPLFPDTVACRT
QGNFCRAGACPPTFTISGQCHGGLLNCCAKIPAQ
69
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Antimicrobial Activity Assay
MIC assays for the peptides were performed by two-fold broth
dilution method with Mueller Hinton II broth according to the
procedures as suggested by the CLSI (Clinical and Laboratory
Standards Institute) (Wayne, 2009, 2012). In summary, Bacteria
and Candida were grew to reach out the exponential phase. Cells
were then centrifuged at 2000 × g for 15min. The resulting pel-
lets were washed and resuspended in 10mM sodium phosphate
buffer saline solution (pH 7.0). Two-fold serial dilutions of the
sAvBD-4 and 10 were prepared in appropriate culture medium
in 96-microwell plates. 100µL inoculum from the culture with a
bacterial density of 106 CFU/ml were added to each individual
well containing 100µL of either M-H alone, or M-H contain-
ing two-fold diluted peptide to give a final concentration of the
peptide ranging from 0 to 200µM. MIC values were recorded as
the minimum concentration that showed no visible growth after
overnight incubation at 37◦C. The cell survival percentage was
determined by measuring the absorbance at λ = 570 nm with a
microplate reader. Cell survival % = [(mean optical density of
the sample − blank)/(mean optical density of the control ((no
treatment)− blank)]× 100.
The minimum bactericidal concentration (MBC) or the min-
imum fungicidal concentration (MFC) were evaluated by sub-
culture of the contents of the first two clear wells obtained in
the MIC assay onto minimal M-H agar plates. The lowest pep-
tide concentration yielding more than 99% of either bacterial or
fungal growth inhibition was noted as MBC or MFC.
Two multicellular fungi (Asp. niger and Asp. flavus) were
used to evaluate the anti-fungal activity of those two peptides.
Overnight cultures of the fungi were prepared by inoculating
100ml of Sabouraud dextrose broth with a 105 spores/ml con-
centration. Tetracycline used as a reference in the case of both
Gram-negative and positive bacteria. On the other hand, Keto-
conazole was use as a reference in the case of the fungus C. albi-
cans, Asp. Niger, and Asp. flavus. The both reference antibiotics
were used at concentration of (30µg/ml).
Kinetics of Inactivation
In order to study the kinetics of bacterial inactivation for both
of the test peptides, three organisms were used: MRSA, and E.
coli (1 × 108 CFU/ml) and C. albicans (1 × 108 CFU/ml). The
concentration used was two times of that of the MIC. Overnight
bacterial cultures were prepared. The cultures were spun down
and resuspended in fresh M-H medium at a concentration of
1 × 108 CFU/ml. sAvBD-4 and 10 were then added to the bacte-
rial suspension, at a concentration equivalent to two times that of
the MIC. The mixture was incubated under 35◦C. Ten-microliter
aliquots were removed with a sterile calibrated loop at (0, 15, 30,
60, 120, and 180min) and uniformly seeded on M-H medium
(Ma et al., 2011). The plates were incubated at 35◦C for 24–
48 h. After the incubation period, the number of viable cells was
counted and expressed in CFU/ml. The results were analyzed and
represented graphically, a microbial death curve as a function of
time.
Salinity Test
E. coli was used as a test model to evaluate the effects of ionic
strength on the antibacterial activity of the two peptides. E. coli
was subcultured at 37◦C to the mid-log phase, and suspended to
106 CFU/ml in MH. A suspension of E. coli (1ml) was incubated
with different concentrations of peptides (0–200µg/mL), with
different concentrations of NaCl (0, 20, 50, 150mM) in 10mM
sodium phosphate buffer, pH 7.4. The tested bacteria was cul-
tured at 37◦C for 2 h before 1000 times of dilution followed by
plating. Survived bacteria were counted (Ma et al., 2011; Wang
et al., 2011; Baricelli et al., 2015).
Hemolysis Test
The hemolytic activities of the synthetic defensin were investi-
gated according to what has been reported in the literature (Shin
et al., 2001; Yu et al., 2001). Briefly, fresh chicken blood was col-
lected from King Abdulaziz University farm, Jeddah, KSA. The
blood was spun down for erythrocytes harvesting by centrifu-
gation (3000 rpm, 10min, at 20◦C). The resulting erythrocytes
were then washed twice with sterile PBS at a concentration of
0.5% vol/vol and were used for the assay, by dispensing 90µl
into each well of the 96-well plates. Ten microliters of differ-
ent peptides concentrations were added to the cells and incu-
bated at 37◦C for 2 h. After incubation, the microtiter was spun
down at 800 × g for 10min. The supernatants were withdrawn
and transferred to a new 96-well plate and checked for released
hemoglobin as measured spectrophotometerically at 405 nm. For
(0 hemolysis) as well as (100% hemolysis) controls, cells were
resuspended in PBS only and in 1% Triton X-100, respectively
(Ma et al., 2013).
Statistical Analysis
Data were entered using IBM SPSS Statistics 20, and was analyzed
by Kaplan–Meier analysis. A P level of < 0.05 was considered to
significant.
Results
The chicken β-defensin (sAvBD-4 and 10) used in this study were
analogs of the natural peptides. These were custom made hav-
ing the linear N-terminal acetylated as is the case with naturally
occurring mature chicken β-defensin peptides. These custom-
made peptides were evaluated for their anti-bacterial and anti-
fungal activities against 10 bacterial strains and three fungal
species. There was a variation in the response of the bacte-
ria to the tested peptides with sAvBD10 showing a better effi-
cacy on average against all the bacteria tested. Statistical analyses
showed that the difference was significant at the 95% as shown
in (Table 2, Figures 1A,B). The results showed that sAvBD-4
inhibited the growth of both Gram-negative and positive bacte-
ria with MIC concentrations as follows: 25µg/ml [(Staph. epi-
dermidis, Kleb. pneumonia, Sh. sonnei, C. albicans), 50µg /ml
(MRSA, M. luteus, Salm. typhimurium, E. coli, Asp. flavus) and
100µg/ml for (Str. bovis, Ent. faecalis, Asp. niger)]. However,
sAvBD-10 was more efficient in achieving bacterial inactivation
at the following MIC concentrations: 25µg/ml (M. luteus, Kleb.
pneumonia, C. albicans, and Asp. flavus) and 50µg/ml (Str. bovis,
Ent. faecalis, MRSA, Salm. typhimurium, E. coli, Staph. epider-
midis, Sh. sonnei, Asp. niger, and P. aeruginosa). The MBC levels
were also determined and found to be two-fold higher than those
of the corresponding MIC values (MBC range, 50–200µg/ml)
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TABLE 2 | The antimicrobial activities of synthetic chicken β-defensin-4 and 10-derived peptide.
Organisms species sAvBD-4 peptide sAvBD-10 peptide Tetracycline
Bacteria MIC (µg/ml) MBC (µg/ml) MIC (µg/ml) MBC (µg/ml) MIC (µg/ml) MBC (µg/ml)
Str. bovis ATCC (49147) < 100± 0.0 200±0.0 50± 0.0 100±0.58 10± 3.46 20±0.0
Staph. epidermidis ATCC (12228) 25± 3.46 100±0.58 50± 0.0 100±0.58 10± 1.73 10±0.0
Staph. aureus MRSA ATCC (43330) 50± 0.0 100±1.0 50± 1.3 100±1.0 20± 0.0 < 20±1.73
Ent. faecalis ATCC (29212) 100± 0.0 200±0.58 50± 0.0 100±1.73 10± 0.0 20±0.0
M. luteus ATCC (49732) 50± 3.0 50±1.58 25± 0.0 50±1.73 5± 0.0 10±0.0
E. coli ATCC (25922) 50± 1.3 100±0.00 50± 1.73 100±3.46 10± 0.0 20±1.73
P. aeruginosa ATCC (27853) – – 50± 0.0 200±3.46 10± 1.73 20±1.73
Salm. typhimurium ATCC (14028) 50± 0.58 100±3.46 50± 0.58 100±3.46 10± 0.0 20±0.0
Kleb. pneumonia ATCC (700603) 25± 0.0 50±0.58 25± 0.0 100±1.73 5± 0.0 20±0.0
Sh. sonnei ATCC (25931) 25± 3.46 100±3.46 50± 1.73 100±0.58 5± 0.0 10±1.0
Fungi MFC MFC Ketoconazole
C. albicans ATCC (10231) 25± 1.0 100±0.58 25± 0.0 50±0.58 3± 0.0 3±0.0
Asp. Flavus 50± 1.0 100±3.46 25± 0.0 50±0.58 10± 0.0 25±0.0
Asp. Niger 100± 1.73 – 50± 3.0 100±1.3 10± 0.0 10±0.0
Determination of MICs (µg/ml) and MBCs (µg/ml), or MFCs (µg/ml) for each peptide and bacteria was performed at least three-times in doublets. sAvBD-4, synthetic chicken
β-defensin-10; sAvBD-10, synthetic chicken β-defensin-10; MIC, minimal inhibition concentration; MBC, minimal bactericidal concentration; MFC, minimal fungicidal concentration.
(Table 2). At those lower concentrations, sAvBD-10 had a sig-
nificantly better antimicrobial activity as compared to sAvBD-4
against all the bacteria tested (P < 0.002). However, at higher
concentrations of 100µg/ml, both peptides showed no significant
difference in their bactericidal efficacy (Table 2).
There was a dose dependent decline in antifungal inhibition
and inactivation by both peptides (Table 2). Again, sAvBD-10
showed a significantly better anti-fungal activity as compared to
sAvBD-4 as far as both MIC and MFC are concerned. In the case
of sAvBD-10 (Figure 1B), the MIC varied among the three fungi
with 25µg/ml needed for both C. albicans and Asp. flavus and
50µg/ml for Asp. niger. There was a significant difference in the
MIC reported regarding sAvBD-4 among the three fungal species
tested (Table 2, Figure 1B) with highestMIC observed in the case
of Asp. niger.
The data showed that the MFC activity of sAvBD-10 was
25µg/ml in the case of C. albicans and Asp. flavus and 50µg/ml
forAsp. niger. Amuch higher concentration was needed concern-
ing sAvBD-4 (Table 2, Figure 1B). A better bactericidal activity
was noted in the case of tetracycline as compared to the tested
peptides. This, also, applies in the case of ketoconazole.
Kinetics of Inactivation
In the kinetics study, MRSA, E. coli, and C. albicans were used
(Figure 2). Both peptides showed similar efficacy against MRSA
during the first hour of application. However, faster decline was
prominent in the case of sAvBD-4 for the next 2 h. This was not
the case in term of E. coliwhere the two peptides started the same
for the first hour and sAvBD-10 produced higher bactericidal effi-
cacy for the remaining 2 h. As far as the kinetics of killing of C.
albicans is concerned, there was a consistent better efficacy of
sAvBD-10 over sAvBD-4.
Salinity Test
The effect of salinity on the antibacterial efficacy of both pep-
tides was evaluated using various salt concentrations ranging
from 0 to 150mM (Figure 3). The results revealed that the syn-
thetic peptide’s efficacy was not reduced in the presence of salt
concentrations ranging from 0 to 50mM. However, such an
effect was significantly compromised in a dose dependent man-
ner when higher concentrations of salt were present (Figure 3)
(P < 0.001).
Hemolytic Activity of Synthetic Peptide
The hemolytic activities of the two peptides were evaluated
using freshly isolated chicken erythrocytes. The hemolysis was
done using spectrophotometric measurements at a wavelength of
405 nm (Figure 4). The results showed that the peptides did not
produce significant hemolytic effects.
Discussion
Around 1000 HDP has been discovered so far. The β-defensins,
cathelicidens and liver antimicrobial peptide-2 are three of those
HDPs that originated from chickens. In this investigation, the
antimicrobial potential of two synthetic peptides (AvBD-4 and
10) was evaluated against 10 Gram-positive and -negative bac-
terial strains, as well as unicellular and multicellular fungi. This
work was initiated to better understand the efficacy of those novel
peptides against bacteria and fungi and their possible applica-
tion in conjunction either with already existing antimicrobial
agents or with possible substitutes for them. The uncontrolled
use, misuse, and abuse of commonly administered antimicro-
bial agents has resulted in the horizontal gene transfer among
microorganisms and led to the stimulation of the evolution-
ary potential of the bacteria to develop some kind of resistance
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FIGURE 1 | Continued
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FIGURE 1 | Antimicrobial activities of synthetic chicken β-defensin-4 and 10-derived peptide (sAvBD) against (A) bacteria and (B) Fungal species. All
assays were performed in three independent experiments and each point is the mean ± SE, (P < 0.002).
against the antimicrobial agents and consequently resulted in
the emergence of multi-drug resistant bacteria. Such a resistance
to antimicrobials is a worldwide problem in the treatment of
infectious diseases especially in patients who are immunocom-
promised patients with hospital-acquired infections. For this rea-
son, alternative agents have been sought to deal with the issue of
multi-drug resistance. The AMPs are naturally occurring prod-
ucts, which have undergone a long-term evolution in nature.
These peptides may have a promising potential as possible sub-
stitutes for antimicrobial agents or to potentiate the efficacy of
already existing drugs used for the treatment of infectious agents.
The findings of this study revealed that the synthetic AvBD-
4 and 10 displayed a potent efficacy against a broad-spectrum
of bacteria. The current results were compatible with those of
other studies on the antimicrobial activity of other known AvBDs
(Evans et al., 1994, 1995; Harwig et al., 1994; Thouzeau et al.,
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FIGURE 2 | The kinetic inactivation of synthetic chicken β-defensin-4 and 10-derived peptide (sAvBD) against MRSA, E. coli and C. albicans species.
All assays were performed in three independent experiments and each point is the mean ± SE.
2003; Lynn et al., 2004; Higgs et al., 2005; van Dijk et al., 2008;
Ma et al., 2009a,b, 2011, 2012a,b,c; Soman et al., 2010; Wang
et al., 2010; Zhang et al., 2011, 2012). For instance, geese derived
synthetic peptides showed an effect against both Gram-positive
and -negative bacteria, like S. aureus and E. coli, thus consis-
tent with the findings on synthetic β-defensins potency in their
natural forms as reported elsewhere (Sass et al., 2010; Ma et al.,
2013). The results of a study on recombinant AvBD2 derived
from ducks exhibited a strong bactericidal potential against B.
cereus, S. aureus, and P. multocid, and weak bactericidal activity
against E. coli and S. choleraesuis like the results obtained using
defensins (Evans et al., 1994; Harwig et al., 1994; Yu et al., 2001;
Thouzeau et al., 2003; Sugiarto and Yu, 2006), were chemically
synthesized (Higgs et al., 2005; van Dijk et al., 2007) or were pro-
duced by recombinant expression (Milona et al., 2007; van Dijk
et al., 2007; Ma et al., 2008). In another study using Recombinant
HBD2 showed that it inhibited three Gram-negative bacteria
known for their resistant to antimicrobial agents (S. marcescen,
P. aeruginosa, A. baumannii) that are opportunistic nosoco-
mial pathogens present among immunocompromised individu-
als (Baricelli et al., 2015).
Interestingly, besides the broad spectrum of antibacterial
effect, the synthetic AvBD-4 and 10 exhibited a fungicidal activity
against both unicellular and multicellular fungi. More than 90%
fungicidal activity was reported in this study. It was interesting
to note that avian derived peptides have an anti-fungal poten-
tial. The results showed for the first time that those avian pep-
tides had inhibitory and cidal effects against fungi. Also, it was
reported that defensin secreted by filamentous fungi displayed
strong inhibitory potential against human and plant infectious
agents (Lacadena et al., 1995; Meyer, 2002, 2008; Marx, 2004;
Galgóczy et al., 2010).
The differences in the inactivation kinetics between the two
peptides may be structure related and/or dependent on the type
bacteria used. Studies demonstrated that pheasant cathelicidin-
1 (Pc-CATH1) inhibited E. coli growth during the first hour of
application. However, it took 6 h for the bacterial growth to be
resumed (Wang et al., 2011). The killing kinetics for synthetic
sAvBD-10 was more effective than sAvBD-4 in eliminating fungal
species than bacteria as indicated in this investigation.
Salt resistance is a defiance that is highly pertinent for HDPs
in order for them to exert their full potential under physiologi-
cal conditions. The results showed that the NaCl levels as those
found under physiological conditions found in the human body
did not compromise the efficacy of the tested peptides. Similar
to those present in the Similar to other defensins (Sang et al.,
2005; Ma et al., 2011). The efficacies of those peptides were com-
promised in the presence of high salt concentrations. This is
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FIGURE 3 | Effects of salinity on the antibacterial activity of synthetic chicken β-defensin-4 and 10-derived peptide (sAvBD) against E. coli. All assays
were performed in three independent experiments and each point is the mean ± SE, (P < 0.001).
consistent with the findings reported by others (Soman et al.,
2010) and those of others using ostrich (Ma et al., 2013; Lu et al.,
2014). The results revealed that the effect of ionic strength on
the antimicrobial impact of investigated peptides were compat-
ible with other reports on most tested defensins and other AMPs
(Porter et al., 1997; Bals et al., 1998; Zucht et al., 1998; Veldhuizen
et al., 2008).
Furthermore, the antimicrobial potency of synthetic AvBD-
4 and 10, these synthetic peptides had low hemolytic effect and
low toxicity at higher concentrations. These results are in agree-
ment with other studies on other avian β-defensin and also for
mammals defensin (Milona et al., 2007; Veldhuizen et al., 2008;
Ma et al., 2011, 2012a,c). Some published studies indicated that
the little toxic effect of defensin peptide on animal cells might be
due to the partly higher cholesterol levels and a lack of negatively
charged phospholipids in the outer leaflet of animal membranes,
which inhibit the binding of many AMPs (Matsuzaki et al., 1995;
Ishitsuka et al., 2006). This in agreement with the data obtained
by other scientists using geese and duck related defensins (Ma
et al., 2013; Lu et al., 2014).
The mechanism of action by which those peptides these pep-
tides exert their effects is not well-understood. It is likely to be
due to interaction of the peptides which are positively charged
with specific structures like the phospholipid membranes found
on the negatively charged bacterial membrane. The result of the
interaction of the peptides with the phospholipid membranes,
will lead to an increase in the pore formation of the membrane
which result in increased permeability leading to the demise of
the bacterial cell (Zasloff, 2002; van Dijk et al., 2008; Derache
et al., 2009; Ma et al., 2013; Lu et al., 2014).
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FIGURE 4 | Hemolytic activities of synthetic chicken β-defensin-4 and
10-derived peptides (sAvBD). All assays were performed in three
independent experiments and each point is the mean ± SE.
Conclusion
The antimicrobial activity of synthetic chicken β-defensin-4 and
10 were studied against wide spectrum of infectious pathogens,
including bacterial and fungal species. These peptides have exhib-
ited significant antimicrobial activities against a broad spec-
trum of Gram-positive and Gram-negative bacteria of concern
to the public health and have been involved in many outbreaks.
Interestingly, besides their broad spectrum of antibacterial activ-
ities, synthetic AvBD (4 and 10) have shown fungicidal potential
against C. albicans and Asp. flavus. The results showed that the
synthetic AvBD (4 and 10) weremore efficacious as an anti-fungal
agents causing more than 95% reduction in fungi as compared
to the control. Both of those synthetic peptides were resistant to
salt concentrations of 50mM NaCl, but lost their antimicrobial
potential in a milieu containing salt concentration of 100 and
150mMNaCl. Based on the data, it would be concluded that syn-
thetic β-defensin peptides have a potent antimicrobial activities
against a broad spectrum of pathogens and would merit the need
for more studies to investigate their full potential in the treatment
of disease in both humans and animals. They are likely to be a
possible alternative to antibiotics and serve as natural antimicro-
bial properties with the hope that they do not produce bacteria
that are resistant due to their naturally occurring properties.
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